Biomea Fusion Enters Material Definitive Agreement
Ticker: BMEA · Form: 8-K · Filed: Jun 18, 2025 · CIK: 1840439
| Field | Detail |
|---|---|
| Company | Biomea Fusion, Inc. (BMEA) |
| Form Type | 8-K |
| Filed Date | Jun 18, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, filing
TL;DR
Biomea Fusion just signed a big deal, filing an 8-K today.
AI Summary
On June 17, 2025, Biomea Fusion, Inc. entered into a material definitive agreement. The company, incorporated in Delaware with its principal executive offices in Redwood City, CA, filed an 8-K report detailing this event. The filing also includes other events and financial statements and exhibits.
Why It Matters
This filing indicates a significant new contract or partnership for Biomea Fusion, which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, the specifics of which are not detailed in this initial filing.
Key Players & Entities
- Biomea Fusion, Inc. (company) — Registrant
- June 17, 2025 (date) — Earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Redwood City, CA (location) — Principal Executive Offices
FAQ
What type of material definitive agreement did Biomea Fusion, Inc. enter into?
The filing states that Biomea Fusion, Inc. entered into a material definitive agreement on June 17, 2025, but does not specify the nature of the agreement.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on June 17, 2025.
Where are Biomea Fusion, Inc.'s principal executive offices located?
Biomea Fusion, Inc.'s principal executive offices are located at 900 Middlefield Road, 4th Floor, Redwood City, CA 94063.
What is Biomea Fusion, Inc.'s fiscal year end?
Biomea Fusion, Inc.'s fiscal year end is December 31.
What is the SIC code for Biomea Fusion, Inc.?
The Standard Industrial Classification (SIC) code for Biomea Fusion, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 regarding Biomea Fusion, Inc. (BMEA).